Toho : Notice Regarding Completion of Payment Concerning Disposal of Treasury Stock as Restricted Stock Compensation(141 KB)
August 25, 2021
Share
August 26, 2021
To whom it may concern:
Company Name
TOHO HOLDINGS CO., LTD.
Corporate
Atsushi Udoh, President and Representative
Representative
Director
(First Section of Tokyo Stock Exchange
Securities Code:8129)
Contact:
Makoto Kawamura, Director and General
Manager, Corporate Management Division
and Corporate Planning and Investor
Relations Department
(TEL: 81-3-6838-2803)
Notice Regarding Completion of Payment Concerning Disposal of Treasury Stock
as Restricted Stock Compensation
TOHO HOLDINGS CO., LTD. (hereinafter, the "Company") hereby announces that, payment procedures were completed today as follows for the disposal of treasury stock as restricted stock compensation, which was resolved at its Board of Directors' meeting held on July 27, 2021. For details, please refer to "Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation," which was announced on July 27, 2021.
Outline of Disposal
(1)
Class and number of shares
Common Stock of the Company 25,000 shares
to be disposed
(2)
Disposal value
1,916 yen per share
(3)
Total disposal value
47,900,000 yen
(4)
Acquirers
of
disposed
The Company's Directors (excluding those who are Audit and
Toho Holdings Co. Ltd. published this content on 26 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 September 2021 09:01:01 UTC.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.